Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate versus delayed insertion of intrauterine contraception at the time of medical abortion
2018-000287-29Phase 3Active
- Sponsor
- Karolinska Institutet
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of avatrombopag, levonorgestrel intrauterine system and LoviOne (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Use of intrauterine contraception at 6 months. Started Jan 2018; status: active.
02
Drugs
avatrombopaglevonorgestrel intrauterine systemLoviOne
Beyond the preview
Go deeper on 2018-000287-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000287-29.